Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Silo Pharma Inc (NQ: SILO ) 1.200 +0.070 (+6.19%) Streaming Delayed Price Updated: 3:59 PM EDT, Sep 5, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Silo Pharma Inc < Previous 1 2 3 4 5 6 7 8 9 10 Next > PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Announces Data Supporting SPC-14’s Therapeutic Potential for Alzheimer’s October 20, 2022 Via Investor Brand Network Exposures Product Safety What Is Going on With Silo Pharma (SILO) Stock Today? October 20, 2022 Silo Pharma (SILO) stock is falling on Thursday despite the company releasing positive data from a pre-clinical Alzheimer's study. Via InvestorPlace Alzheimer’s Pipeline of New Treatments Race to Improve Quality of Life for Patients October 20, 2022 Palm Beach, FL – October 20, 2022 – FinancialNewsMedia.com News Commentary – Last year, about 6.2 million people aged 65 and above living in America were suffering from Alzheimer’s disease, (AD) which... Via FinancialNewsMedia Silo Pharma Extends Alzheimer's Therapeutics Research Pact October 18, 2022 Via Benzinga Silo Pharma Announces Data Supporting Therapeutic Potential of SPC-14 for Alzheimer’s Disease in Pre-Clinical Study October 20, 2022 Dosing study of SPC-14 demonstrates efficacy for increasing memory function Englewood Cliffs, NJ – October 20, 2022 – Silo Pharma, Inc. (Nasdaq: SILO) (“the Company”), a developmental stage... Via FinancialNewsMedia Silo Pharma Posts Encouraging Preclinical Data For Alzheimer's Candidate October 20, 2022 Silo Pharma Inc (NASDAQ: SILO) has announced proof-of-concept data supporting the therapeutic potential of SPC-14 as a treatment for Alzheimer's disease (AD). The research was conducted as part of a... Via Benzinga Silo Pharma Announces Data Supporting Therapeutic Potential of SPC-14 for Alzheimer’s Disease in Pre-Clinical Study October 20, 2022 Dosing study of SPC-14 demonstrates efficacy for increasing memory function From Silo Pharma, Inc. Via GlobeNewswire Psychedelics For Alzheimer's And Stress-Induced Disorders Under Study At Columbia University October 18, 2022 Silo Pharma Inc. Via Benzinga Florida Dispensary Uncovers Legal Loophole, Starts Selling Shrooms October 18, 2022 Via Investor Brand Network Topics Law Enforcement Exposures Legal PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Announces Agreement with Columbia University to Extent Research Pact October 18, 2022 Via Investor Brand Network Silo Pharma extends research pact for Alzheimer’s and Stress Induced Anxiety Therapeutics October 18, 2022 Silo and Columbia University continue research on SPC-14 for Alzheimer’s and SPC-15 for Stress Induced Disorders From Silo Pharma, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's Intraday Session October 13, 2022 Gainers Via Benzinga Silo Pharma Stock Higher After Investors Appraise Innovative Treatment For Nerve Pain And Neurological Disorders ($SILO) October 13, 2022 Via AB Newswire Exposures Product Safety Legislators in New York File Revised Measure to Legalize Psychedelics October 12, 2022 Via Investor Brand Network PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Initiates Safety Evaluation Study of Its Novel Time-Released Ketamine Formulation October 10, 2022 Via Investor Brand Network Silo Pharma Initiates Toxicity Study of its Proprietary Ketamine Formulation for Treatment of Fibromyalgia October 10, 2022 From Silo Pharma, Inc. Via GlobeNewswire Silo Pharma’s Mission To Merge Traditional Pharmaceuticals With Psychedelic Compounds Can Be A Treatment Game-Changer For Neurological Disorders ($SILO) October 10, 2022 Via AB Newswire Exposures Product Safety Researchers Develop Psychedelic Compound with No Hallucinogenic Effects, Can Treat Depression October 06, 2022 Via Investor Brand Network PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) to Participate at Upcoming Dawson James Small Cap Growth Conference October 06, 2022 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Silo Pharma to Present at the Dawson James Small Cap Growth Conference on October 12 October 06, 2022 From Silo Pharma, Inc. Via GlobeNewswire Silo Pharma Inc. (NASDAQ: SILO) Successfully Uplists, Commences Trading on the Nasdaq Market October 05, 2022 Via Investor Brand Network How Psychedelic Integration Coaches Help Facilitate Healing October 04, 2022 Via Investor Brand Network PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Preparing for Ketamine Tech FDA Pre-Investigational New Drug Package October 03, 2022 Via Investor Brand Network Exposures Product Safety Silo Pharma Initiates FDA Pre-Investigational New Drug (IND) Package for Time-Released Ketamine Technology October 03, 2022 From Silo Pharma, Inc. Via GlobeNewswire PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Secures $5.75M in Underwritten Public Offering September 30, 2022 Via Investor Brand Network Silo Pharma Announces Closing of $5.75 Million Public Offering of Common Stock, Nasdaq Listing, and Full Exercise of Underwriter’s Over-Allotment Option September 30, 2022 From Silo Pharma, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's Pre-Market Session September 30, 2022 Gainers Ainos (NASDAQ:AIMD) shares increased by 46.4% to $2.02 during Friday's pre-market session. The market value of their outstanding shares is at $39.3 million. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday September 30, 2022 Good morning, investor! We're closing out the trading week with a breakdown of the biggest pre-market stock movers for Friday! Via InvestorPlace Why Amylyx Pharmaceuticals Is Trading Higher By Over 8%; Here Are 22 Stocks Moving Premarket September 30, 2022 Gainers SAI.TECH Global Corporation (NASDAQ: SAI) rose 42% to $3.21 in pre-market trading after dipping 26% on Thursday. SAI.TECH recently announced the launch of new liquid cooling Bitcoin mining... Via Benzinga Breakthrough Test May Make It Easier to Diagnose Parkinson’s Using Skin Swabs September 29, 2022 Via Investor Brand Network < Previous 1 2 3 4 5 6 7 8 9 10 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.